Last $135.00 USD
Change Today +2.20 / 1.66%
Volume 31.3K
BAYRY On Other Exchanges
Symbol
Exchange
OTC US
Xetra
OTC US
BrsaItaliana
Xetra
Mexico
Continuous
As of 8:10 PM 10/23/14 All times are local (Market data is delayed by at least 15 minutes).

bayer ag-sponsored adr (BAYRY) Snapshot

Open
$133.56
Previous Close
$132.80
Day High
$135.68
Day Low
$133.40
52 Week High
09/22/14 - $146.62
52 Week Low
11/1/13 - $122.65
Market Cap
111.6B
Average Volume 10 Days
74.0K
EPS TTM
--
Shares Outstanding
826.9M
EX-Date
04/25/14
P/E TM
--
Dividend
$2.90
Dividend Yield
2.14%
Current Stock Chart for BAYER AG-SPONSORED ADR (BAYRY)

bayer ag-sponsored adr (BAYRY) Related Bloomberg News

View More Bloomberg News

bayer ag-sponsored adr (BAYRY) Details

Bayer Aktiengesellschaft develops, produces, and markets health care and agricultural products, and high-tech polymer materials worldwide. The company operates through HealthCare, CropScience, and MaterialScience segments. The HealthCare segment offers prescription pharmaceuticals, such as contraceptives, hemophilia treatments, anticoagulants, and medicines to treat multiple sclerosis, cancer, hypertension, and infectious diseases; and consumer health products comprising over-the-counter medications, dermatology products, nutritional supplements, veterinary medicines, and animal grooming products. This segment also provides medical care products, including blood glucose monitoring devices, such as single-strip and multi-strip systems; USB meters that feature integrated diabetes management software and direct plug-in to computers; contrast agent injection systems for diagnostic and therapeutic medical procedures in computed tomography, magnetic resonance imaging, and molecular imaging; and mechanical systems for removing thrombi from blood vessels, as well as service products for its systems. The CropScience segment offers products for use in agriculture as insecticides, fungicides, and herbicides or seed treatments; seeds and plant traits; and various products for gardens, green industry, and nonagricultural pest control. The MaterialScience segment provides high-tech polymer materials in the areas of polyurethanes, polycarbonates, coating and adhesive raw materials, and functional films; and produces and markets inorganic basic chemicals. The company has a strategic alliance with OncoMed Pharmaceuticals, Inc. to develop drugs to target cancer stem cell therapeutics. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

115,487 Employees
Last Reported Date: 07/29/14
Founded in 1863

bayer ag-sponsored adr (BAYRY) Top Compensated Officers

Chairman of Management Board and Chief Execut...
Total Annual Compensation: €2.9M
Chief Strategy & Portfolio Officer and Member...
Total Annual Compensation: €1.8M
Labor Director and Member of Management Board
Total Annual Compensation: €1.1M
Compensation as of Fiscal Year 2013.

bayer ag-sponsored adr (BAYRY) Key Developments

Bayer Announces Sales Results for the Period of January-June of 2014; Provides Earnings Guidance for the Year 2017

Bayer announced sales results for the period of January-June of 2014. The company's Japan sales grew 11.6% to JPY 144.5 billion in the January-June period compared to the same period a year earlier The company is targeting sales of JPY 300 billion (USD 2.8 billion) in Japan by 2017.

Bayer AG Appoints Otmar D. Wiestler to the Supervisory Board

The Local Court of Cologne has appointed Professor Otmar D. Wiestler (57) to the Supervisory Board of Bayer AG. He replaces Dr. Klaus Kleinfeld (56), who left the Supervisory Board at his own request effective September 30, 2014, in order to concentrate on his other offices and honorary posts, some of which are in the United States. Since January 1, 2004, Wiestler has been Chairman of the Management Board and Scientific Director of the German Cancer Research Center (DKFZ) in Heidelberg, Germany. Also since 2004 he has been Chairman of the Advisory Committee and a member of the board of German Cancer Aid. From 2007 to 2012, he was a Vice-President in the Executive Committee of the Helmholtz Association. Kleinfeld has been Chief Executive Officer of U.S. metals and technology company Alcoa Inc. since May 2008. He joined the Supervisory Board of Bayer AG on April 29, 2005.

Bayer Seeks Acquisitions

Bayer AG (DB:BAYN) is looking for acquisitions. Marijn Dekkers, Chief Executive Officer of Bayer said, "We intend to continue the expansion of our attractive over-the-counter business both through organic growth and bolt-on acquisitions".

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAYRY:US $135.00 USD +2.20

BAYRY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GlaxoSmithKline PLC 1,419 GBp +6.50
Merck & Co Inc $56.63 USD +1.12
Pfizer Inc $28.60 USD +0.30
Sanofi €84.60 EUR -0.30
Dow Chemical Co/The $47.68 USD +0.07
View Industry Companies
 

Industry Analysis

BAYRY

Industry Average

Valuation BAYRY Industry Range
Price/Earnings 22.6x
Price/Sales 2.0x
Price/Book 4.1x
Price/Cash Flow 22.6x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-SPONSORED ADR, please visit www.bayer.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.